Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31319446 | 0.81 | ALDH1A1 (0.33) | ANPEPLAP3 | |
| SCHEMBL31319433 | 0.78 | — | — | |
| SCHEMBL31319430 | 0.78 | — | — | |
| SCHEMBL20510142 | 0.76 | ANPEP (0.35) | ANPEPLAP3 | |
| SCHEMBL20510144 | 0.76 | ANPEP (0.35) | ANPEPLAP3 | |
| SCHEMBL23969644 | 0.76 | ANPEP (0.35) | ANPEPLAP3 | |
| SCHEMBL20510143 | 0.76 | ANPEP (0.35) | ANPEPLAP3 | |
| SCHEMBL28355908 | 0.76 | ANPEP (0.35) | ANPEPLAP3 | |
| SCHEMBL20764142 | 0.75 | ANPEP (0.50) | ANPEPLAP3 | |
| SCHEMBL31423666 | 0.74 | ANPEP (0.37) | ANPEPLAP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250059215-A1 | Trifluoroborate (BF3) Compositions For Use In Boron Neutron Capture Therapy and Methods Thereof | TAE LIFE SCIENCES, LLC | 2025-02-20 | — | — | US | disclosed |
| WO-2025034812-A2 | TRIFLUOROBORATE (BF3) COMPOSITIONS FOR USE IN BORON NEUTRON CAPTURE THERAPY AND METHODS THEREOF | TAE LIFE SCIENCES LLC (US) | 2025-02-13 | — | — | WO | disclosed |
| US-11014943-B2 | Azetidine derivative | CHIA TAI TIANQING PHARMACEUTICAL GROUP GO., LTD. (CN) | 2021-05-25 | — | — | US | disclosed |
| US-20200115392-A1 | AZETIDINE DERIVATIVE | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) | 2020-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11014943-B2 | Azetidine derivative | BCL9, MCL1, BCL9L | ANPEP 256/4885LAP3 2636/4885 |
| US-20200115392-A1 | AZETIDINE DERIVATIVE | BCL9, MCL1, BCL9L | ANPEP 256/4885LAP3 2636/4885 |
| US-20250059215-A1 | Trifluoroborate (BF3) Compositions For Use In Boron Neutron Capture Therapy and Methods Thereof | BCL3, BRS3, BCL9 | ANPEP 2159/4885LAP3 774/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.